An antibody against the "don't eat me" signal on cancer cells appears safe and well-tolerated by patients with advanced cancers. A phase 2 trial is planned.
A Stanford neurobiologist takes on the challenge of explaining neuroscience in a series of brief videos on Instagram, five a week for an entire year.
Using human embryonic stem cells to study nicotine's effect in development shows defects in cellular communication and longevity, say Stanford scientists.
Cracking the crystal structure of a protein complex centered around a major immune signaling protein, interferon-gamma, may speed its medical use.
Scientists at Stanford have developed a tool that helps them track "off-target" gene edits that come as an accidental result of gene editing.
Intestinal tissue can be cultured in the form of little hollow "gutballs." To make them more useful, scientists figured out how to turn them inside out.
With a DNA test, Dani Shapiro discovered that the man she had thought was her father was not. She discussed the finding, and her writing, on campus.
A Stanford clinic found that staying in close contact with patients virtually between appointments achieved dramatic health improvements. Can additional technology build on those gains?
In most babies and kids, the sound of their mother's voice gets special treatment in the brain. But in autism, this distinctive brain response is lessened.
Orthopaedic surgeon Constance Chu has spent her career seeking ways to prevent osteoarthritis from developing after a knee injury.
Withdrawing or withholding invasive medical treatments to keep very ill patients in the ICU comfortable and communicative may not hasten their death.
Female scientists could be losing ground as a result of research funding review methods that favor men, two Stanford researchers say.
Scientists have created an algorithm that works to generate and refine DNA sequences that are likely to code for antimicrobial proteins.
If you happened to have dropped by the Apple Store in downtown San Francisco Monday evening, you might have caught sight of something out of …
You've already knew our modern high-fat, high-sugar, high-starch, minimal-fiber diet was going to be the death of us all, because you've been told a thousand times. Now, a new study in mice gives us yet another reason to watch our intake.
Antibody-based hematopoietic stem cell transplants may transform the treatment of patients with blood and immune diseases including cancers.
